Tag: pricing

Basel, July 8, 2025 – Novartis today announced Coartem^® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet^® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

Hong Kong, July 07, 2025 (GLOBE NEWSWIRE) -- Masonglory Limited (the “Company”), is a Hong Kong based subcontractor providing wet trades and related ancillary services to private and public sectors, today announced the pricing of its initial public offering (the “Offering”) of 1,500,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per share. The Company expects to receive aggregate gross proceeds of approximately $6 million, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on July 8, 2025 under the ticker symbol “MSGY”. The Offering is expected to close on July 9, 2025, subject to the satisfaction of customary closing conditions. In addition, the Company has granted the underwriters an option (the “Over-Allotment Option”), within 45 days from the closing date of the Offering, to purchase up to an additional 225,000 Ordinary Shares at the public offering price, less underwriting discounts, to cover the Over-Allotment Option, if any.

Celebration, FL, July 07, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0, a major enhancement to the Company’s proprietary agent platform. The new version, which went live on July 1, 2025, features a fully integrated Transaction Management module that is intended to deliver significant cost savings to the Company by improving efficiency, reducing manual processes, and eliminating reliance on expensive third-party systems.

SHREWSBURY, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a purpose-built Layer 1 blockchain for artificial intelligence infrastructure, has initiated its Bonus Round token offering after completing 15 successful presale stages and raising a total of $20.9 million.

SHREWSBURY, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a blockchain infrastructure project focused on AI-native applications, has completed all 15 presale phases without delays and is now entering its Bonus Round. The project has raised $21 million to date, with tokens continuing to be available at a fixed price of $0.007.

SHREWSBURY, United Kingdom, July 06, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a next-generation Layer 1 blockchain platform purpose-built for decentralized artificial intelligence, has officially launched its Bonus Round after completing all 15 presale stages and raising more than $21 million in early contributions. This new phase offers fixed pricing at $0.007125 and is the final opportunity for supporters to gain early access ahead of the project’s mainnet launch, scheduled for July 2025.

SHREWSBURY, United Kingdom, July 06, 2025 (GLOBE NEWSWIRE) -- Lightchain AI a decentralized platform at the intersection of blockchain and artificial intelligence, today announced the launch of its Bonus Round following the successful completion of all 15 presale stages. The project has now raised $21 million, securing strong early participation ahead of its mainnet launch scheduled for July 2025.